#ASCO22, Twitter, 6/9/2022 12:46:10 AM, 277928


FAQ | Problem?

#ASCO22_2022-06-08_15-44-54.xlsx
#ASCO22_2022-06-08_15-44-54.xlsx
From:
Connected Action NodeXL-Reports
Uploaded on:
June 09, 2022
Short Description:
#ASCO22 via NodeXL https://bit.ly/39aLFP7
@asco
@oncoalert
@nuenojpn
@hephaistos_ai
@erictopol
@nejm
@marklewismd
@mskcancercenter
@mdandersonnews
@teamoncology

Top hashtags:
#asco22
#bcsm
#lcsm
#breastcancer
#crcsm
#cancer
#oncology
#rectalcancer
#nsclc

Description:
Description
The graph represents a network of 7,862 Twitter users whose recent tweets contained "#ASCO22", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Wednesday, 08 June 2022 at 23:33 UTC.

The tweets in the network were tweeted over the 2-day, 7-hour, 49-minute period from Monday, 06 June 2022 at 14:54 UTC to Wednesday, 08 June 2022 at 22:44 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

The graph is directed.

The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.

The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.


Author Description


Overall Graph Metrics
Vertices : 7862
Unique Edges : 30458
Edges With Duplicates : 20923
Total Edges : 51381
Number of Edge Types : 5
Retweet : 13381
MentionsInRetweet : 25343
Replies to : 744
Mentions : 9538
Tweet : 2375
Self-Loops : 2495
Reciprocated Vertex Pair Ratio : 0.0675422138836773
Reciprocated Edge Ratio : 0.126537785588752
Connected Components : 302
Single-Vertex Connected Components : 205
Maximum Vertices in a Connected Component : 7376
Maximum Edges in a Connected Component : 50553
Maximum Geodesic Distance (Diameter) : 13
Average Geodesic Distance : 3.5699
Graph Density : 0.000570812033593998
Modularity : 0.362832
NodeXL Version : 1.0.1.449
Data Import : The graph represents a network of 7,862 Twitter users whose recent tweets contained "#ASCO22", or who were replied to or mentioned in those tweets, taken from a data set limited to a maximum of 18,000 tweets. The network was obtained from Twitter on Wednesday, 08 June 2022 at 23:33 UTC.

The tweets in the network were tweeted over the 2-day, 7-hour, 49-minute period from Monday, 06 June 2022 at 14:54 UTC to Wednesday, 08 June 2022 at 22:44 UTC.

Additional tweets that were mentioned in this data set were also collected from prior time periods. These tweets may expand the complete time period of the data.

There is an edge for each "replies-to" relationship in a tweet, an edge for each "mentions" relationship in a tweet, and a self-loop edge for each tweet that is not a "replies-to" or "mentions".

Layout Algorithm : The graph was laid out using the Harel-Koren Fast Multiscale layout algorithm.
Graph Source : TwitterSearch
Graph Term : #ASCO22
Groups : The graph's vertices were grouped by cluster using the Clauset-Newman-Moore cluster algorithm.
Edge Color : Edge Weight
Edge Width : Edge Weight
Edge Alpha : Edge Weight
Vertex Radius : Betweenness Centrality

Top Influencers: Top 10 Vertices, Ranked by Betweenness Centrality
Top URLs
Top URLs in Tweet in Entire Graph:
[353] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[169] https://myriad.com/oncology/precise/
[153] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[145] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home&cookieSet=1
[60] http://onconexion2022.com
[33] https://bit.ly/3mlp3Ou
[32] https://www.linkedin.com/pulse/what-look-asco-2022-advances-precision-medicine-health-thomas-slavin/
[30] https://myriad.com/investors/news-releases/news-release-detail/?newsItemId=23106
[26] https://evidence.nejm.org/doi/full/10.1056/EVIDoa2100070?cookieSet=1
[26] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445

Top URLs in Tweet in G1:
[21] https://meetings.asco.org/2022-asco-annual-meeting/14350?presentation=207038#207038
[17] http://www.OncoAlert360.com
[16] https://twitter.com/jrgralow/status/1533857425991811073
[15] https://ecancer.org/en/video/10418-asco-2022-highlights-and-analysis
[15] https://www.aacr.org/professionals/research/aacr-project-genie/the-aacr-project-genie-biopharma-collaborative-bpc/bpc-nsclc-2-0-public/
[14] https://ascopubs.org/doi/10.1200/JCO.22.01003?cookieSet=1
[12] https://meetings.asco.org/abstracts-presentations/206720
[12] https://evidence.nejm.org/doi/full/10.1056/EVIDoa2100070?cookieSet=1
[12] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[12] https://twitter.com/OncoAlert/status/1533827005329833986

Top URLs in Tweet in G2:
[20] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[14] https://twitter.com/ThejusJay/status/1533873552595771393
[13] https://evidence.nejm.org/doi/full/10.1056/EVIDoa2100070?cookieSet=1
[11] https://www.forbes.com/sites/victoriaforster/2022/06/01/risk-of-skin-cancer-depends-on-genetics-as-well-as-sun-exposure-says-new-study/?sh=4c75bd263b80
[10] https://ascopubs.org/doi/10.1200/JCO.22.00839?cookieSet=1
[10] https://meetings.asco.org/abstracts-presentations/207687
[10] https://twitter.com/FlavioRochaMD/status/1533877127858163712
[10] https://twitter.com/JenSeligmann/status/1533834638279442433
[8] https://aacrjournals.org/cancerdiscovery/collection/64/Clinical-Trials
[8] https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)32319-0/fulltext

Top URLs in Tweet in G3:
[20] https://www.statnews.com/2022/06/06/black-cancer-patients-not-offered-access-to-clinical-trials?utm_content=buffer380fe&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic
[14] https://www.nytimes.com/2022/06/07/health/enhertu-breast-cancer-chemotherapy.html?smid=tw-share
[14] https://www.statnews.com/2022/06/06/black-cancer-patients-not-offered-access-to-clinical-trials/
[14] https://twitter.com/CancerTrialCork/status/1128572603990458370
[12] https://www.healthpopuli.com/2022/06/07/jasper-scaling-a-human-touch-for-people-dealing-with-cancer/
[7] https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/CARVYKTI-pi.pdf
[7] https://www.statnews.com/2022/06/05/with-the-right-molecular-signal-a-cancer-drug-works-in-every-patient/
[6] https://www.sciencedirect.com/science/article/abs/pii/S0167814022000366
[6] https://www.astrazeneca.com/what-science-can-do/topics/next-generation-therapeutics/breast-cancer-research.html?utm_source=twitter&utm_medium=asco+congress+2022&utm_term=11469&utm_content=onc&linkId=167804427
[6] http://gyncsm.blogspot.com/

Top URLs in Tweet in G4:
[55] http://onconexion2022.com
[9] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137742-asco-2022-abstract-5040-safety-and-survival-outcomes-in-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-lutetium-177-prostate-specific-membrane-antigen-?mtm_campaign=Rahbar_SocialASCO22_ID137742
[9] https://breakthroughsforphysicians.nm.org/northwestern-medicine-american-society-of-clinical-oncology-2022.html?utm_source=social_media&utm_medium=twitter_p&utm_campaign=reputation_oncology_may_2022&utm_id=oncology&utm_content=oncology
[9] https://www.clonoseq.com/technical-summary
[9] https://meetings.asco.org/abstracts-presentations/208194
[9] https://meetings.asco.org/2022-asco-annual-meeting/14376?presentation=207154#207154
[8] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137689-asco-2022-a-phase-iii-double-blinded-study-of-early-intervention-after-radical-prostatectomy-with-adt-with-darolutamide-versus-placebo-in-men-at-highest-risk-of-prostate-cancer-metastasis-b?mtm_campaign=Morgans_SocialASCO22_ID137689
[8] https://twitter.com/stephenvliu/status/1533944435632898050
[7] https://meetings.asco.org/2022-asco-annual-meeting/14370?presentation=212277#212277
[7] https://www.urotoday.com/conference-highlights/asco-2022/asco-2022-prostate-cancer/137714-asco-2022-predictive-value-of-extra-prostatic-disease-detection-by-pre-operative-psma-pet-for-biochemical-recurrence-free-survival-in-patients-treated-with-radical-prostatectomy-follow-up-a?mtm_campaign=Djaileb_SocialASCO22_ID137714

Top URLs in Tweet in G5:
[303] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[24] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445
[20] https://www.mskcc.org/news-releases/asco-2022-100-complete-response-rate-mmrd-locally-advanced-rectal-cancer-seen-pivotal-immunoablative-neoadjuvant-immunotherapy-clinical-trial
[10] https://www.mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
[10] https://www.nejm.org/doi/full/10.1056/NEJMoa2203690
[9] https://www.parcdesalutmar.cat/ca/noticies/view.php?ID=12151
[8] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[6] https://www.mskcc.org/news/trastuzumab-deruxtecan-t-dxd-treating-her2-low-breast-cancer-shows-promise
[5] http://www.nejmgroup.org/
[4] https://www.parcdesalutmar.cat/es/noticies/view.php?ID=1579

Top URLs in Tweet in G6:
[26] https://bit.ly/3mlp3Ou
[12] https://www.mdanderson.org/newsroom/studies-reveal-new-insights-into-gut-microbiome-impact-on-immunotherapy-response-in-multiple-cancers-including-glioblastoma.h00-159540534.html
[11] https://meetings.asco.org/abstracts-presentations/search?q=*
[7] https://www.mdanderson.org/newsroom/studies-reveal-new-insights-into-gut-microbiome-impact-on-immunotherapy-response-in-multiple-cancers-including-glioblastoma.h00-159540534.html?cmpid=twitter
[7] https://twitter.com/ravinratan/status/1533889909320306693
[7] https://idp.nature.com/authorize?response_type=cookie&client_id=grover&redirect_uri=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-022-01726-1
[6] https://bit.ly/3GRjAIW
[6] https://www.mdanderson.org/AllisonInstitu
[6] https://ascopubs.org/doi/full/10.1200/EDBK_351123?cookieSet=1
[5] https://www.mdanderson.org/ClinicalTrials

Top URLs in Tweet in G7:
[5] https://www.nejm.org/doi/full/10.1056/NEJMoa2203690?query=featured_home&cookieSet=1
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?cookieSet=1
[3] https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202206/575420.html
[2] https://ascopubs.org/doi/full/10.1200/JCO.22.00908?cookieSet=1
[2] https://togetter.com/li/1896226
[2] https://twitter.com/drcmassard/status/1534205767913455619
[2] https://twitter.com/OncBrothers/status/1533947802493063170
[2] https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202206/575378.html
[1] https://medical.nikkeibp.co.jp/leaf/all/cancernavi/news/202206/575419.html
[1] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445

Top URLs in Tweet in G8:
[6] https://www.saluteh24.com/il_weblog_di_antonio/2022/06/tumore-del-retto-tasso-di-risposta-completa-al-100-senza-chirurgia-radio-e-chemio-asco22.html
[4] https://www.saluteh24.com/il_weblog_di_antonio/2022/06/asco-e-oms-collaborano-agli-indicatori-di-qualit%C3%A0-per-le-strutture-oncologiche-congresso-asco22-a-chicago.html
[4] https://www.saluteh24.com/il_weblog_di_antonio/2022/06/tumore-del-seno-gli-oncologi-dell-asco22-estendono-utilizzo-dei-test-genomici.html
[3] https://twitter.com/i/status/1533420142872371200
[2] https://www.twitlonger.com/show/n_1ss23j0
[2] https://endpts.com/asco22-biontech-says-mrna-vaccine-safe-in-15-of-16-patients-with-deadly-pancreatic-cancer/
[2] https://endpts.com/asco22-enhertu-blows-chemotherapy-out-of-the-water-redefining-breast-cancer-subgroups-along-the-way/
[2] https://caringambassadors.org/
[2] https://www.saluteh24.com/il_weblog_di_antonio/2022/06/tumore-al-seno-sacituzumab-govitecan-migliora-la-sopravvivenza-asco22.html
[2] http://www.salutedomani.com/article/tumore_del_retto_tasso_di_risposta_completa_al_100_senza_chirurgia_radio_e_chemio_asco22_33745

Top URLs in Tweet in G9:
[7] https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-workshop-7th-annual-clinical-outcome-assessment-cancer-clinical-trials-workshop-06292022
[7] https://www.surveymonkey.com/r/COACCT22
[6] https://www.biocentury.com/article/643940/pazdur-rings-bell-for-dose-optimization-wants-to-modernize-clinical-tox
[4] https://www.fiercebiotech.com/medtech/asco-her2-diagnostics-need-revolution-astrazeneca-daiichis-enhertu-looks-redefine-breast
[3] https://meetings.asco.org/2022-asco-annual-meeting/14302?presentation=204313#204313
[3] https://www.biocentury.com/article/643927/how-new-modalities-against-cd20-stack-up-at-asco
[3] https://www.biocentury.com/topics/asco-2022?utm_source=twitter&utm_medium=socialmedia&utm_campaign=asco22
[3] https://www.biocentury.com/article/643937
[3] https://twitter.com/ilanaschlam/status/1534149465841582084
[3] https://note.com/nijuoti/n/nf400d0db3fc1

Top URLs in Tweet in G10:
[130] https://www.nejm.org/doi/full/10.1056/NEJMoa2201445?query=featured_home&cookieSet=1
[130] https://www.nytimes.com/2022/06/05/health/rectal-cancer-checkpoint-inhibitor.html
[4] https://www.nejm.org/doi/full/10.1056/NEJMoa2200075?query=featured_home&cookieSet=1
[4] https://www.nejm.org/doi/full/10.1056/NEJMe2204625?query=recirc_curatedRelated_article&cookieSet=1
[1] https://twitter.com/drteplinsky/status/1533532538450370562
[1] https://www.statnews.com/2022/06/06/black-cancer-patients-not-offered-access-to-clinical-trials?utm_content=buffer380fe&utm_medium=social&utm_source=twitter&utm_campaign=twitter_organic

Top Domains
Top Domains in Tweet in Entire Graph:
[2086] twitter.com
[652] nejm.org
[583] asco.org
[397] ascopubs.org
[255] myriad.com
[237] urotoday.com
[183] nytimes.com
[109] onclive.com
[108] ascopost.com
[98] com.br

Top Domains in Tweet in G1:
[936] twitter.com
[175] asco.org
[131] ascopubs.org
[77] onclive.com
[64] nejm.org
[61] ascopost.com
[35] medicinematters.com
[28] aacrjournals.org
[25] urotoday.com
[22] ecancer.org

Top Domains in Tweet in G2:
[463] twitter.com
[148] ascopubs.org
[146] asco.org
[61] nejm.org
[37] oncologytube.com
[35] wiley.com
[22] healio.com
[19] cancer.gov
[11] aacrjournals.org
[11] thelancet.com

Top Domains in Tweet in G3:
[180] twitter.com
[47] statnews.com
[40] asco.org
[37] medscape.com
[32] ascopost.com
[30] ascopubs.org
[24] healio.com
[18] nytimes.com
[13] astrazeneca.com
[12] healthpopuli.com

Top Domains in Tweet in G4:
[202] urotoday.com
[143] twitter.com
[80] asco.org
[57] onconexion2022.com
[37] cgtlive.com
[33] targetedonc.com
[29] cancernetwork.com
[23] ascopubs.org
[16] medpagetoday.com
[13] cor2ed.com

Top Domains in Tweet in G5:
[347] nejm.org
[40] mskcc.org
[22] twitter.com
[13] parcdesalutmar.cat
[13] vhio.net
[8] nytimes.com
[5] nejmgroup.org
[4] onclive.com
[4] nih.gov
[4] ascopubs.org

Top Domains in Tweet in G6:
[65] twitter.com
[54] nature.com
[41] asco.org
[37] mdanderson.org
[37] bit.ly
[22] ascopubs.org
[12] obroncology.com
[8] urologytimes.com
[7] ppd.com
[6] bmj.com

Top Domains in Tweet in G7:
[10] nejm.org
[6] co.jp
[4] twitter.com
[2] ascopubs.org
[2] togetter.com

Top Domains in Tweet in G8:
[73] com.br
[37] twitter.com
[18] saluteh24.com
[8] mdedge.com
[7] endpts.com
[6] linkedin.com
[5] salutedomani.com
[4] dy.si
[4] asco.org
[4] medscape.com

Top Domains in Tweet in G9:
[19] twitter.com
[19] biocentury.com
[9] asco.org
[7] fda.gov
[7] surveymonkey.com
[6] note.com
[4] bms.com
[4] nejm.org
[4] fiercebiotech.com
[3] ascopubs.org

Top Domains in Tweet in G10:
[138] nejm.org
[130] nytimes.com
[1] twitter.com
[1] statnews.com

Top Hashtags
Top Hashtags in Tweet in Entire Graph:
[19627] asco22
[1323] bcsm
[1243] lcsm
[855] breastcancer
[607] crcsm
[572] cancer
[508] oncology
[442] rectalcancer
[338] nsclc
[294] prostatecancer



Top Hashtags in Tweet in G1:
[7301] asco22
[1006] lcsm
[599] bcsm
[322] breastcancer
[214] nsclc
[149] lungcancer
[146] cancer
[141] crcsm
[140] gerionc
[130] oncology

Top Hashtags in Tweet in G2:
[3487] asco22
[409] crcsm
[189] bcsm
[141] colorectalcancer
[106] lcsm
[92] oncoalerttoptweet
[86] breastcancer
[72] clecliniccancer
[68] precisionmedicine
[67] cancer

Top Hashtags in Tweet in G3:
[1797] asco22
[285] bcsm
[230] breastcancer
[222] cancer
[87] clinicaltrials
[85] oncology
[53] gyncsm
[51] cancerresearch
[37] immunotherapy
[35] womeninoncology

Top Hashtags in Tweet in G4:
[1881] asco22
[226] leusm
[202] mmsm
[143] prostatecancer
[87] mpnsm
[66] cedarssinaicancer
[65] lymsm
[62] onconexion22
[59] lcsm
[58] bcsm

Top Hashtags in Tweet in G5:
[746] asco22
[335] rectalcancer
[52] gyncsm
[43] immunotherapy
[41] asco22vr
[38] ovariancancer
[16] parpi
[13] dynamic
[13] càncerdecòlon
[13] oncologia

Top Hashtags in Tweet in G6:
[836] asco22
[130] endcancer
[56] sarcoma
[42] immunotherapy
[41] melanoma
[34] bcsm
[29] mpnsm
[25] oncology
[23] lymsm
[19] nsclc

Top Hashtags in Tweet in G7:
[384] asco22
[3] 乳がん
[3] sacituzumabgovitecan
[2] 肺がん
[2] nsclc
[2] cln081
[1] breastcancer
[1] bcsm
[1] ras遺伝子野生型
[1] 大腸がん

Top Hashtags in Tweet in G8:
[344] asco22
[45] oncologiabrasil
[43] mdhealth
[17] oncology
[12] câncerdepróstata
[10] câncerdemama
[9] câncerdeovário
[8] asco2022
[8] asco
[8] câncerdepulmão

Top Hashtags in Tweet in G9:
[310] asco22
[35] bcsm
[22] kpatasco
[15] lcsm
[10] cancer
[9] clinicaltrials
[8] immunotherapy
[7] oceoutcomes22
[7] patientreportedoutcomes
[6] breastcancer

Top Hashtags in Tweet in G10:
[136] asco22
[1] oncoalerttoptweet
[1] destinybreast04

Top Words
Top Words in Tweet in Entire Graph:
[19637] #asco22
[4787] asco
[4255] cancer
[3968] patients
[2891] oncoalert
[2600] dr
[1952] trial
[1912] study
[1716] more
[1603] great

Top Words in Tweet in G1:
[7287] #asco22
[2110] asco
[1513] oncoalert
[1368] cancer
[1159] patients
[1149] dr
[1006] #lcsm
[708] great
[622] poster
[604] data

Top Words in Tweet in G2:
[3492] #asco22
[969] asco
[946] oncoalert
[943] cancer
[715] patients
[490] dr
[410] #crcsm
[349] more
[336] trial
[314] study

Top Words in Tweet in G3:
[1814] #asco22
[553] cancer
[475] patients
[313] asco
[285] #bcsm
[242] #cancer
[231] breast
[229] #breastcancer
[220] trials
[204] clinical

Top Words in Tweet in G4:
[1889] #asco22
[515] asco
[449] patients
[303] trial
[293] study
[244] gt
[240] cancer
[226] #leusm
[213] dr
[212] presented

Top Words in Tweet in G5:
[747] #asco22
[458] nejm
[387] advanced
[381] asco
[380] response
[375] published
[368] locally
[368] mskcancercenter
[361] clinical
[348] deficient

Top Words in Tweet in G6:
[837] #asco22
[191] patients
[173] dr
[146] trial
[144] cancer
[130] #endcancer
[130] presented
[121] asco
[116] mdandersonnews
[112] study

Top Words in Tweet in G7:
[384] #asco22
[349] 04
[347] がんの治療開発でホームランを打つことは滅多にない
[347] 今回チームで取り組んだdestiny
[347] 臨床試験は
[347] ホームランだった
[347] 満場総立ちの拍手喝采
[347] を始めて研究者として
[347] シカゴで経験した
[347] ホルモン陽性転移性乳がんに新しい治療が到来する

Top Words in Tweet in G8:
[344] #asco22
[102] em
[61] estudo
[53] cancer
[45] #oncologiabrasil
[43] #mdhealth
[39] patients
[36] conteúdo
[36] completo
[35] asco

Top Words in Tweet in G9:
[307] #asco22
[117] patients
[107] oncoalert
[100] her2
[89] research
[85] metastatic
[78] low
[77] drgattimays
[76] presented
[74] think

Top Words in Tweet in G10:
[260] complete
[260] remission
[136] #asco22
[135] cancer
[134] patients
[130] single
[130] patient
[130] unheard
[130] '
[130] combining

Top Word Pairs
Top Word Pairs in Tweet in Entire Graph:
[1402] asco,#asco22
[839] breast,cancer
[838] #asco22,oncoalert
[623] lung,cancer
[551] mismatch,repair
[551] #asco22,#lcsm
[547] repair,deficient
[505] locally,advanced
[438] learn,more
[425] #asco22,asco

Top Word Pairs in Tweet in G1:
[632] asco,#asco22
[475] #asco22,#lcsm
[420] #asco22,oncoalert
[374] lung,cancer
[303] breast,cancer
[216] #asco22,#bcsm
[177] #asco22,asco
[171] #asco22,dr
[157] poster,discussion
[134] session,#asco22

Top Word Pairs in Tweet in G2:
[261] #asco22,oncoalert
[219] asco,#asco22
[189] #asco22,#crcsm
[145] colorectal,cancer
[111] lung,cancer
[107] #crcsm,oncoalert
[100] breast,cancer
[95] day,#asco22
[95] rectal,cancer
[91] #asco22,asco

Top Word Pairs in Tweet in G3:
[205] breast,cancer
[132] clinical,trials
[81] #bcsm,#asco22
[79] presented,#asco22
[76] metastatic,breast
[71] patients,metastatic
[70] 40,black
[69] #asco22,oncoalert
[69] destiny,breast04
[68] learn,more

Top Word Pairs in Tweet in G4:
[164] gt,asco
[160] #asco22,written
[160] written,coverage
[128] #asco22,#leusm
[98] asco,pcfnews
[93] coverage,walliscjd
[88] walliscjd,uoft
[86] #asco22,dr
[84] uoft,gt
[81] #mmsm,#asco22

Top Word Pairs in Tweet in G5:
[368] locally,advanced
[347] deficient,locally
[344] mismatch,repair
[344] repair,deficient
[334] published,nejm
[325] asco,#asco22
[324] complete,response
[316] advanced,#rectalcancer
[310] 100,clinical
[310] dostarlimab,alone

Top Word Pairs in Tweet in G6:
[51] #asco22,#endcancer
[40] asco,#asco22
[38] first,human
[30] booth,6122
[30] clinical,trial
[27] james,allison
[27] read,phase
[26] gut,microbiome
[26] session,#asco22
[23] antitumor,activity

Top Word Pairs in Tweet in G7:
[347] がんの治療開発でホームランを打つことは滅多にない,今回チームで取り組んだdestiny
[347] 今回チームで取り組んだdestiny,04
[347] 04,臨床試験は
[347] 臨床試験は,ホームランだった
[347] ホームランだった,満場総立ちの拍手喝采
[347] 満場総立ちの拍手喝采,を始めて研究者として
[347] を始めて研究者として,#asco22
[347] #asco22,シカゴで経験した
[347] シカゴで経験した,ホルモン陽性転移性乳がんに新しい治療が到来する
[347] ホルモン陽性転移性乳がんに新しい治療が到来する,成功の余韻を楽しんでいる

Top Word Pairs in Tweet in G8:
[42] #mdhealth,#oncologiabrasil
[41] em,#mdhealth
[36] completo,em
[32] conteúdo,completo
[22] em,pacientes
[20] saiba,mais
[20] mais,em
[19] neste,vídeo
[16] estudo,clínico
[16] dados,estudo

Top Word Pairs in Tweet in G9:
[74] her2,low
[71] practice,changing
[70] thinking,incorporate
[68] wrapping,#asco22
[68] #asco22,thinking
[68] incorporate,practice
[68] changing,research
[68] research,presented
[68] presented,her2
[68] low,change

Top Word Pairs in Tweet in G10:
[260] complete,remission
[130] remission,single
[130] single,patient
[130] patient,unheard
[130] unheard,'
[130] ',combining
[130] combining,genomics
[130] genomics,diagnosis
[130] diagnosis,mismatch
[130] mismatch,repair

Top Replied-To
Top Replied-To in Entire Graph:
@asco
@marklewismd
@dralanburguete
@pashtoonkasi
@mdandersonnews
@neerajaiims
@benjaminbessemd
@chiaracrem1
@y_loriot
@myriadgenetics

Top Replied-To in G1:
@ibiayimd
@neerajaiims
@benjaminbessemd
@devikadasmd
@anavmanana
@asco
@ravikanesvaran
@montypal
@ginadamatomd1
@norinansarimd

Top Replied-To in G2:
@pashtoonkasi
@marklewismd
@asco
@chiaracrem1
@benweinbergmd
@funchainmd
@arunsekhri
@drsgraff
@oncoalert
@skabrajimd

Top Replied-To in G3:
@kznhealth
@lesleykailani
@mary_huckle
@advbmkhwebane
@adicetbio
@eibhlinmulroe
@luucymuurphy
@nooneatnowhere
@jrgralow
@erikahamilton9

Top Replied-To in G4:
@asco
@uchicagohemonc
@nadalernest
@henryjoncology
@dranitakumar
@immutep
@dr_amerzeidan
@drenriquegrande
@lindamileshkin
@anis_a_hamid

Top Replied-To in G5:
@dralanburguete
@sabrinaycamp
@su2cscience

Top Replied-To in G6:
@mdandersonnews
@y_loriot
@huanglabicr
@janeway_md
@drvijaypatil11
@ginadamatomd1
@marklewismd
@thalcin
@jjkiladjian
@stephenvliu

Top Replied-To in G7:
@teamoncology
@mdandersonnews

Top Replied-To in G8:
@itneditor

Top Replied-To in G9:
@drgattimays
@adicetbio
@lundjenny
@livenlet_thai
@drrobinyabroff

Top Mentioned
Top Mentioned in Entire Graph:
@asco
@oncoalert
@nejm
@mskcancercenter
@weoncologists
@erikahamilton9
@mdandersonnews
@drsgraff
@danafarber

Top Mentioned in G1:
@asco
@oncoalert
@weoncologists
@stephenvliu
@danafarber
@viveksubbiah
@grecondomd
@conquercancerfd
@charuaggarwalmd

Top Mentioned in G2:
@oncoalert
@asco
@weoncologists
@chiaracrem1
@nejm
@americancancer
@manjuggm
@thenci
@mskcancercenter
@smitha42

Top Mentioned in G3:
@asco
@oncoalert
@tigerlilycares
@mbcalliance
@erikahamilton9
@faceofstage4
@jhaveri_komal
@mskcancercenter
@chrysalisinit
@cancertrials_ie

Top Mentioned in G4:
@asco
@pcfnews
@walliscjd
@uoft
@zklaassen_md
@cscancercare
@gacancercenter
@cedarssinaimed
@oncoalert
@gecp_org

Top Mentioned in G5:
@nejm
@asco
@mskcancercenter
@andreacercek
@oncoalert
@claramontagut
@joanavidalb
@imim_research
@dsolit

Top Mentioned in G6:
@asco
@mdandersonnews
@oncoalert
@nassifelise
@anaingmd
@pamsharmamdphd
@cathy_ileana_md
@jimallisonphd
@profglongmia
@mpdrc

Top Mentioned in G7:
@oncoalert
@jacobadashek
@hirotakamd
@dr_r_kurzrock
@mdandersonnews
@merregan
@danafarber

Top Mentioned in G8:
@oncocytecorp

Top Mentioned in G9:
@oncoalert
@drgattimays
@erikahamilton9
@drsgraff
@stolaney1
@asco
@pkluetz
@biocentury
@unc_lineberger
@fdaoncology

Top Mentioned in G10:
@drteplinsky
@weoncologists

Top Tweeters
Top Tweeters in Entire Graph:
@uber_support
@chidambara09
@guldeen
@gambiste1
@united
@baarahk
@lizditz
@repubblica
@netminnow
@reuters

Top Tweeters in G1:
@robtropper
@raivoonet
@unitedspacecats
@washingtonpost
@ilimlevebilimle
@thaiparampil
@pash22
@drferdowsi
@tomvarghesejr
@todayshow

Top Tweeters in G2:
@united
@repubblica
@brontyman
@claimcompanies
@holliejoyjoy
@pkanagaratnam
@paulmcclintock
@cnn
@monitor_ph
@molliekatie

Top Tweeters in G3:
@chidambara09
@netminnow
@reuters
@gwydion620
@ml_tweet_bot
@nanteos620
@nytimes
@blueravefinn
@profilo3marco
@segalink

Top Tweeters in G4:
@kaleidoscopet0
@telegraph
@grumpeoldman
@marvinharris76
@thetimes
@evidencerobot
@evelyns51868235
@immigrants24
@dnaed_tech
@pierre018

Top Tweeters in G5:
@baarahk
@tates5a
@jazzmanahn
@aldu_maria
@shafeeu
@sirfizz
@g_lame3
@mogulazam
@rosario_strano
@eedaii

Top Tweeters in G6:
@straitarrow10
@belladonamodels
@mumaralid
@smilenewa
@passarelliallan
@grandma_hockey
@oma_hamou
@lwiebeld
@dannyleblanc24
@dorothyeubank16

Top Tweeters in G7:
@guldeen
@longlow1
@namunohi
@eimc3z
@fuku_chihuahua
@dasew01
@towano_yamanako
@hassegawa
@tabolabo
@skalanote

Top Tweeters in G8:
@amainsight
@angelotani
@salutedomani
@richmeyer
@boobstagramm
@_b_i_o_t_e_c_h_
@mloxton
@pymarketwatch
@bethematch
@nad1223

Top Tweeters in G9:
@kh_hokujinigrtc
@bccww
@jinwonjung
@liz_oriordan
@pharmaphorum
@gammagrama
@karranfinlay
@samceda
@biocentury
@radioncbotjp

Top Tweeters in G10:
@deepvard
@tighnacoille
@baronianconsult
@mxxntraveler
@fireandmars
@patalucrecia
@mferrini
@db_is_db
@asraghunath
@tonynicol3


We use necessary cookies to make our site work. We’d like to set additional cookies to understand site usage, make site improvements and to remember your settings. We also use cookies set by other sites to help deliver content from their services.